Possible safety issue spurs pause of COVID-19 antibody study By Marilynn Marchione and Linda A. Johnson - Associated Press Shares
Study shows hydroxychloroquine benefits that would help Trump: author By Rowan Scarborough - The Washington Times Shares
Companies testing vaccines pledge safety, high standards By LINDA A. JOHNSON - Associated Press Shares
Trump tears into FDA, speculates ‘deep state’ delaying coronavirus vaccine until after election By Andrew Blake - The Washington Times Shares
FDA blocks much-anticipated BioMarin hemophilia gene therapy By LINDA A. JOHNSON - Associated Press Shares
The Latest: South Korea has 3rd day of 200-plus new cases By The Associated Press - Associated Press Shares
Federal agencies appeal suspension of abortion pill rule By MICHAEL KUNZELMAN - Associated Press Shares
Trump defends disproved COVID-19 treatment By DARLENE SUPERVILLE and AMANDA SEITZ - Associated Press Shares
Feds partner with Pfizer to supply up to 600 million coronavirus vaccine doses By David Sherfinski - The Washington Times Shares
Expert warns it will be ‘challenging’ to keep low virus rate By SUSAN HAIGH - Associated Press Shares
Pfizer, BioNTech win FDA fast-track approval for two coronavirus vaccine candidates By David Sherfinski - The Washington Times Shares
Judge: Women can get abortion pill without doctor visits By MICHAEL KUNZELMAN - Associated Press Shares
‘Desperation science’ slows the hunt for coronavirus drugs By MARILYNN MARCHIONE - Associated Press Shares